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In the present review article human diseases caused by various groups 
of pathogens have been explained with its etiology, epidemiology and 
treatment. In addition, effect of climatic changes on parasites and pathogens 
has been demarcated with rising incidences of diseases. In response to 
environmental changes, mainly external and internal microenvironment 
of body and drug regimens taken by patients; virus is regularly changing 
its form and new mutant variants are coming out. These are circulating in 
many Indian states and cross border countries and causing high infectivity 
and mortality in human patients. These variants with new mutations are 
challenging existing drugs and other prophylactic measures and massively 
disrupting functions of a tissue, organ, or entire organism. Diseases caused 
by viruses are showing new trends in virulence, with high infectivity, 
morbidity and mortality. Due to climatic effect and drug resistance and new 
mutations in pathogens disease burden has been exacerbated enormously at 
global level. In all cases of helminthes, protozoan’s, fungi, bacteria, virus 
pathogens and parasites available drug structure seem to be failed or their 
usefulness has been much reduced due to evolution of new mutant variants 
with multiple drug resistance. There are serious failures at the level of 
operation, management and control of disease. The utmost failure is due 
to lack of appropriate vaccine, drug regimens, clinical care and awareness 













A disease is an abnormal state in which human body 
faces disruption of functions of a tissue, organ, or entire 
organism due to invasion by some pathogen or parasite. 
Though, disease can be symptomatically identified but in 
a few cases its occurrence does not display any symptoms 
and patient remains asymptomatic. Disease may be caused 
by accident due to any causative agent passes on the 
man through some vector, through air, water or by con-
tact. A disease passes through three phases i.e. initiation, 
progression and phase of recovery. There are numerous 
diseases, which display characteristic cause, specific set 
of symptoms, etiology and epidemiology. Among them 
major reasons are invasion by viruses, bacteria, fungi, 
smoking, genetic defects and life style. Life style diseases 
are caused due to eating habits, smoking, drinking, fast 
food, hot items, abnormal day periodicity and un-natural 
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behavior of living (Table 1). There are two major catego-
ries of diseases: communicable and non-communicable. 
Communicable diseases are spread by vectors mainly 
insects, through drinking water, food, soil, and vegeta-
bles. But there are diseases which spread from person to 
person, zoonotic which transmit directly from animal to 
person or by any other mode. Transmission of communi-
cable disease also takes place due to inhalation of aerosols 
present in the air, dust particles, contact with contami-
nated surfaces, blood transfusion, organs transplantation 
and unsafe sexual contact. Common cold, flu, influenza, 
rabies, SARS, and AIDS, are examples of communicable 
diseases. 
After 2001 there has seen a sudden emergence of viral 
and bacterial diseases in tropical and subtropical coun-
tries. There is a surge of microbial and parasitic diseases 
in these climatic regions of the world. Most of the South-
east Asian countries and Australia [1] are in grip of mos-
quito-borne flaviviruses [2] arboviruses and alphaviruses 
enzootics [3]. Four viruses Ebola, Avian flu, MERS and 
Table 1. General, personal, physiological, infectious and public related health disorders.
General health Physiological problems Public Disorders Infectious diseases
Allergies Heart disease Bowel or bladder problems AIDS/HIV Encephalitis
Cold and flu Asthma. Chronic Fatigue Syndrome Autoimmune disorders Malaria
Vomiting and diarrhea Obesity/ Eating disorders Injury Diabetes (genetic) Diarrhea
Fatigue, Diabetes Mental health and depression Eating disorders Jaundice
Meningitis, Stress and Headaches Overweight and obesity Digestive Disorders Leptospirosis
Mononucelosis Depression and anxiety Pain
Food allergies and 
intolerances
Brucellossis
Sinusitis Gastrointestinal problems Pressure sores or ulcers Heart health Hookworm infection
Sore throat Insomnia Heart Disease Goiter Influenza
Urinary tract infection Alzheimer’s disease. Learning Disabilities Overweight and obesity
Tuberculosis and 
Leprosy
Vaginal infection Accelerated aging. Limb Loss Osteoporosis Urinary tract infection
West Nile Virus Premature death. 
Methicillin-resistant 
Staphylococcus aureus (MRSA) 
Infections
Atherosclerosis Respiratory Virus
Fever, Over weight Musculoskeletal Disorders Arthritis Filariasis
Hay fever, Alcoholism Hypothyroidism Hyperthyroidism
Acute Respiratory 
Syndrome
Headache, Sprains and strains






Muscle spasm, Migraine, 
Burns
Heartburn and gastro esophageal 
reflux disease, 
Nephritis, breathing disorders, 
High blood pressure
AIDS
 *Diseases in bold letters will be considered in first category for investigation.
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SARS have been reported highly lethal in 2016 (UNEP 
report, WHO and World Bank). Most of the disease caus-
ing viruses have acquired mutations and showing new 
trends in virulence, high infectivity, morbidity and mortal-
ity. Similarly diseases caused by protozoan parasites are 
hovering with much enhanced parasitemia with extreme 
adaptability, and resistance to all existing drug spectrums. 
Most of the virus generated diseases are suddenly 
emerging due to climatic effects, drug regimens and 
immune defense of host body. Most of the new mutant 
strains of viruses i.e. Rhinovirus, , Respiratory Syncytial 
Virus, Herpes Simplex Virus, Adeno virus, cytomegalovi-
rus, influenza virus Type A, Type B, parainfluenza virus, 
SARS corona virus, poliovirus, HTLV-1, gastroenteritis 
virus, adenovirus, rotavirus, Norovirus, Astrovirus, corona 
virus, pancreatitis coxackie virus, Hepatitis virus A, B, C, 
D, E, dengue, West Nile Virus, Rabies acquired resistance 
against modern pharmaceutics and are circulating in be-
tween various hosts. Most of the virus generated diseases 
are on rise because of attainment of new genetic varia-
tions and resistance to therapeutic drugs and vaccines [4]. 
Recently, W.H. O. has alarmed many countries about new 
waves of infection caused by Ebola virus, Hantavirus as-
sociated with HCPS, Hendra virus, highly pathogenic vi-
rus H5N1, Lassa fever virus, lymphocyte choriomeningitis 
virus, monkey pox virus, Nipah virus, Rabies and Rubella, 
Rota virus B, Chikungunia virus and Yellow fever virus. 
Since 2000 many virus diseases have been re-emerged af-
ter prolonging time. Every year incidence rate of sexually 
transmitted diseases, Herpes simplex virus type 2, human 
papillomavirus, SARS and H1N1 is increasing. All these 
viruses changed its intensity of infection, morbidity and 
mortality rate; even spite of clinical and therapeutic care, 
mortality rate is not lower down. 
2. Viral Diseases
2.1 Japanese Encephalitis
Japanese encephalitis is a major public health problem 
in the Southeast Asian countries that is responsible for 
high morbidity and mortality in pediatric groups. Disease 
occurs almost every year [6]. It is a zoonotic disease caused 
by RNA virus belonging to family flaviviridae [5]. Mosqui-
to Aedes aegypti and Aedes albopictus are main JE virus 
transmission vectors. These mosquitoes breed in large 
numbers in fresh water habitat and through blood feeding 
bites transmitting different JE virus genotypes among 
different hosts. These new genotypes or mutant variants 
are circulating in human population and have established 
themselves in different epidemiological locations i.e. en-
demic to epidemic area, in separate forms. Due to high 
frequency of occasional bites by overlapping population 
of infected mosquitoes mutant variants are interchanging 
its hosts. These mutant variants/new genotypes have been 
detected in the blood samples of local population which 
re-circulate before arrival of rains and filling of water res-
ervoirs with the rain water. This is the main reason of in-
duction of high sero-conversion rate in patients. In North-
ern India a novel mutation (S227T) is domain II of the 
envelope gene of Japanese encephalitis virus circulating 
in North India [7]. Though virus also affects and reservoir 
hosts but human is the main target group. 
In India, in the last 10 years JE incidences have been 
alarmingly increased due to rising vector and vertebrate 
host population in paddy growing areas. Another valid 
reason behind increase in infectivity is invasion of infant 
population by new mutant variants /strains of JEV. This is 
one of the leading causes of high mortality and morbidity 
cases in rural and sub-urban areas. Further, local environ-
ment such as high annual precipitation cycles, frequent 
human travels, demographic clustering, and insecticide 
resistance in target mosquito species has increased the 
endemic area. Other factors are poor economic and socio 
cultural environment and lack of timely therapeutics. In 
addition, presence of revertants epidemiology in the en-
demic area has created an alarming situation. 
So far researches have been done ten stable tempera-
ture-sensitive mutants of Japanese encephalitis virus 
have been artificially generated by mutagenesis. These 
flavivirus mutants are cloned wild-type virus and gener-
ated in the presence of the nucleic acid precursor analogs 
5-fluorouracil and 5-azacytidine. These are inefficient, 
nonreciprocal, and show complementation. But interfer-
ence between mutants is causing mixed infections. Few 
complementing mutants synthesize virus-specific RNA 
at the non-permissive temperature, while other comple-
mentation groups display an RNA+ phenotype. Two other 
groups of mutants synthesize only low levels of virus-spe-
cific proteins at the higher temperature [8]. Mutants in the 
remaining two groups did not produce detectable levels of 
proteins under non-permissive conditions. Few important 
mutants rJEV(nEB1-M41) propagated in N18 cells as 
Beijing-1. Envelope protein mutations L107F and E138K 
are important for neurovirulence attenuation for Japanese 
encephalitis virus SA14-14-2 strain (Table 2).
These m mutants show low virulence but induce high 
immunity in mice after vaccination in a single intraperi-
toneal injection. A high virus yield was obtained from the 
m mutant in tissue culture, with titers of about 10(9.5) 
TCD(50) per ml. These m mutant can be used for the 
preparation of inactivated tissue culture vaccine, but be-
fore exploration of its genetic stability it remains a fiction 
DOI: https://doi.org/10.30564/jasr.v4i2.3229
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Table 2. major virus generated human diseases
Virus causing 




neurovirulence Mosquitoes Birds and pigs
Four genotypes, rJEV(nEB1-M41), 
Envelope protein mutations L107F 
and E138K 
Dengue 
Low blood platelet counts, 
failure of the circulatory system 
and shock
mosquitoes Aedes aegypti 
and Aedes albopictus Mammals
Recombinant dengue virus type 1 
(DV1) strains possess NS3hel protein 
(L435S or L480S




Lungs, GI tract, liver kidney 
and upper respiratory tract
Oxygen deficiency and ASRD, 
Sepsis
Respiratory droplets Man to 
man, Bats, palm, civets
Micro aerosols suspend 
and virus, Mammalian 
laboratory species
Double mutants E484Q and L452R, 
deletion of two amino acids (H146del 
and Y145del), E484K and D614G 
variants in spike protein, RBD 
mutations in L452R and E484Q, 
Triple mutant B1.168 and AP N440
MERS
Sepsis and neurotropic effect 
Nasal and eye discharge, blood, 
ticks, tissue
Rodents Domestic ruminants Single, double and triple mutants
Influenza
Aerosols, feces (birds), 
influenza A (H1N1) and H2N2, 
(H3N2). H1 N2, H2N1, H3N1, 
H2N3
Water bird, ducks
Mammals, poultry, bastard, 
falcons, quail, stone curlew, 
pigeon, dromedaries
Transmission of triple re-assortant 
H3N2 influenza A viruses
Rotaviruses Rotaviruses
Fouling fruit juice drinking, 
ice creams, and drinking 
water 
House fly VP4, NSP1, and NSP4 genes cause virulence
West Nile Virus Neuroinvasive disease and febrile illness
Man to man through blood 
transfusions and organ 
transplants
Mossquito bite Substitution mutation in amino acid in the prM protein
Zika virus High fever mosquito-borne Nonhuman primates Mutation in viral envelope gene (E-V473M)
Rabies Mammals including humans
Wild and stray dogs cats, 
wolves, and, cattle, horses, 
goats and sheep
Dogs and cats
Antigenic mutation in two amino 
acid substitutions in the ectodomain 
of the glycoprotein.
Rubella virus Mammals including humans Stuffy nose and  swollen lymph nodes
Substitution of serine at Cys82 
or deletion of amino acids in  
hydrophobic domain




Buffalo, spring duck, 
Midges, mosquitoes, direct 
or indirect contact with the 
blood or organs of infected 
animals 
Lamb, goat, bovine, calves, 
dromedary, cattle, sheep, 
camels and goats
ZH548 and MP-12-specific 
mutations,
AHF Blood feces, nasal discharges Ticks Sheep, dromedary and others Mutation in envelope protein
Poliomyelitis Paralysis of limbs, nerve dysfunction Air and feces Air and feces
Neurovirulent PV-1 Mahoney strain 
by 55 nucleotide mutations
Mumps virus Meningitis and inflammation of testicles.
Obstruct cellular STAT 
proteins Air




virus type 1 (HIV-1) 
and HIV-2
Acquired immune deficiency 
syndrome 
Man
Blood, semen, vaginal fluids, 
and breast milk.
From HIV infected person 
or by blood transfusion
HIV-1 mutants resistant to NNRTIs, 
CCR5-delta 32
Hantavirus Rodent aerosols, excreta
Rodents, cats, foxes, coyotes, 
Hantavirus Pulmonary 
Syndrome, lungs and kidney
Rodents I532K/S1094L mutations
Marburg/Ebola Reuse of unsterile needles and syringes Green monkey, bats Human
Mutation in soluble glycoprotein 
(sGP or GP)
Enterovirus D68
Acute flaccid myelitis, affect 
nervous system, spinal cord 
gray matter
Air, and direct contact Young children
Mutation in untranslated region 
(UTR) at amino acid position 88 in 
VP3; 1, 148, 282 and 283 in VP1; 22 
in 2A; 47 in 3A. 
Yellow fever Flavivirus, Fever, headache, hemorrhagic Mosquito bites, Monkey and human No Live attenuated vaccine
Chikungunya F togoviridae Mosquito bite A aegypti Arthralgias, hemorrhages No vaccine avoid mosquito bite
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[9]. Though vaccines against JE are available, but there is 
a need to develop a live, attenuated Japanese encephalitis 
vaccine, that can work against its all there genotypes.
2.2 Dengue Hemorrhagic Fever
Dengue is a mosquito-borne Aedes aegypti and Aedes 
albopictus disease caused by dengue virus (DENV). It has 
spread throughout the world and causes hemorrhagic fever 
that continues from 2 to 7 days. As fever declines, warn-
ing signs may develop and smallest blood vessels or cap-
illaries become excessively permeable and large volumes 
of fluid come out from the blood vessels and seep into the 
peritoneum. Viral fever causes low platelet count, arise 
tendency to bruise easily and skin hemorrhages and pleu-
ral effusions in cavity. Patent also display fearful symp-
toms i.e. severe abdominal pain with persistent vomiting, 
red spots or patches on the skin, black, tarry stools (feces, 
excrement), drowsiness or irritability. Patient face diffi-
culty in breathing, profusely bleeds from nose or gums, 
and internal bleeding also occurs This may lead to failure 
of the circulation of blood and initiate shock, and possibly 
death without prompt, and an appropriate treatment. Pa-
tient should provide analgesics (pain relievers) with acet-
aminophen and avoid those containing ibuprofen, naprox-
en, aspirin, or aspirin-containing drugs. They should also 
rest, drink plenty of fluids to prevent dehydration, avoid 
mosquito bites while febrile and consult a physician.
The main reason of infectivity and uncontrolled dengue 
is nonstructural protein 1 (NS1). It is a monomer and a 
cells surface dimer, but it is secreted as hexamer into the 
blood stream. This protein play key role in the viral life 
cycle, mainly assist in RNA replication and immune eva-
sion of the complement pathway. It exerts direct action on 
the vascular endothelium and triggering release of vasoac-
tive cytokines from immune cells. It results in endothelial 
hyper permeability and vascular leak and generates severe 
pathogenesis [10]. In current time four serotypes of dengue 
virus are circulating and keeping half of the human popu-
lation at risk of infection. This is astonishing that all four 
dengue virus serotypes have mutations and are causing a 
serious problem to body’s immune defense, as vaccine or 
antibodies prepared against one serotype could not work 
against second serotype or a different serotype. There-
fore, alternative vaccine strategies should be considered 
long-term safety. Therefore, a composite vaccine is being 
required that can generate ample adaptive immune re-
sponse by inducing production of neutralizing antibodies 
to non-structural protein 1, and reduce the level of patho-
genesis [11]. A dengue virus vaccine named CYD-TDV is 
available in the market, but it is less efficacious and offers 
a limited coverage. 
But there is hope that a cell culture based vaccine can 
be generated by using human monocyte‐derived DCs 
(mdDCs) infected with recombinant dengue virus type 1 
(DV1) strains. These display a single point mutation in the 
NS3hel protein (L435S or L480S). Both mutated viruses 
infect and replicate more efficiently and produce more vi-
ral progeny in infected mdDCs compared with the paren-
tal, non‐mutated virus (vBACDV1) [12]. Few single point 
mutations in subdomain 2 have important implications 
for adenosine triphosphatase (ATPase) activity of DV1‐
NS3hel 
[12]. More specially, there is an utmost need of a 
live attenuated dengue vaccine that is suitable for all age 
groups. It provides a long-term safety covering against 
all infection causing dengue serotypes when injected in 
healthy person [13] (Table 2).
2.3 Hepatitis 
Hepatitis is the inflammation of liver it is caused dif-
ferent types of viruses named A, B, C, D and E. Disease is 
supported by bacterial infections, or continuous exposure 
to alcohol, drugs, or toxic chemicals, aerosol and paint 
thinners or due to an auto-immune disorder. The main 
symptoms of hepatitis are jaundice (yellowing of skin and 
eyes that occurs when the liver fails to break-down ex-
cess yellow-colored bile pigments in the blood. Hepatitis 
results in either damage or reduction in the livers’ ability 
to perform life-preserving functions, including filtering 
harmful, infectious agents from blood, storing blood sugar 
and converting it into usable energy forms, and producing 
many proteins necessary for life. There are five different 
Hepatitis disease types with different symptoms.
Hepatitis A
Hepatitis A is a self-limiting disease that is found all 
across the world. It is usually transmitted through oral in-
gestion of infected material (mainly water), but sometimes 
transmitted parenterally; infection causes symptoms of a 
mild flu attack and jaundice.
Hepatitis B
Hepatitis B is an acute viral disease. It primarily 
spreads parenterally, its main mode of spread is intimate 
contact and from mother to the new born. Patient shows 
mild fever, anorexia, nausea and, vomiting. Later on fe-
verish condition give rise to severe jaundice, urticarial 
skin lesions, arthritis, etc. Some patients become carriers 
or even remain chronically ill, even though most patients 
recover in about three to four months.
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Hepatitis C
It usually occurs after transfusion or parenteral drug 
abuse. It frequently progresses to a chronic form that is 
usually asymptomatic, but may involve liver cirrhosis.
Hepatitis D
Hepatitis D usually occurs as a super infection in case 
of Hepatitis B, with much increased severity.
Hepatitis E
This disease is transmitted by the oral fecal route; usu-
ally by contaminated water. Chronic infection does not 
occur but acute infection may be fatal in pregnant women.
The Hepatitis B virus contains S, P, C, and X genes. 
Among which gene P is largest that codes for synthesis 
of DNA polymerase. Gene S codes synthesis of envelope 
protein (HBsAg) and C gene codes for HBeAg and HB-
cAg [14]. The C gene has a precore and regulates synthesis 
of HBcAg protein product. This is a marker protein as-
sisting in replication and infectivity. A pre-core mutant of 
hepatitis B virus can not replicate and does not produce e 
antigen i.e. HBeAg [14]. All these HBV mutants are dread-
ful and infection caused by these viruses is very difficult 
to treat [15]. Its infection persists for prolonged duration 
and gives rise liver cirrhosis [16]. Hepatitis B viral mutants 
have been emerged in patients due to selection pressure 
from either immune response or treatment options. Muta-
tions that occur within the immunodominant epitopes of 
hepatitis B surface antigen (HBsAg) allow mutant virus 
to propagate in the presence of a neutralizing immune re-
sponse [17]. (Table 2).
2.4 Rotavirus
Rotaviruses are highly pathogenic and cause life-threat-
ening dehydrating gastroenteritis in children and animals. 
Virus contains several genes which regulate formation of 
viral structural proteins V4, VP6, VP7 and non structural 
proteins NSP1, NSP2, NSP3, NSP4 and NSP5 [18] (Table 
2). Virus possesses one nonstructural protein, NSP4 is 
a trans-membrane, and endoplasmic reticulum-specif-
ic glycoprotein is encoded by gene 10. This protein is 
responsible for virulence as it under goes mutations. In 
addition, mutations in three genes i.e. VP4, NSP1, and 
NSP4 are responsible for hike in virulence. Adult diarrhea 
rotavirus (ADRV) strain is detected in eastern U.P. that 
infests larger population due to fowling fruit juice drink-
ing, ice creams, and drinking water and routing fruits. The 
re-emergence of human group B rotavirus (HuGBR) in 
India is a fast growing rotavirus that causes infection very 
fast [18] (Table 2). 
2.5 West Nile Virus
West Nile virus (WNV) is a notable cause of neuro-in-
vasive disease and febrile illness.WNV is transmitted to 
humans and animals through a mosquito bite. Over 60 
species of mosquitoes have been reported transmission 
vectors of West Nile virus. Mosquitoes become infected 
when they feed on infected birds. Human-to-human trans-
mission of WNV does not occur, but it spreads in through 
blood transfusions and organ transplants. Several subtypes 
of WNV lineage 1 have been phylogenetically identified 
in mosquitoes in Israel [19]. From amino sequencing WNV 
virus shows lineage 1 that is identified an amino acid mu-
tation in the prM protein sequence. This mutations mostly 
occurs between day 19 and day 28 of persistent viremia 
and viruria in a person with confirmed WNV encephali-
tis [20] (Table 2). A gene substitution mutation in of a key 
amino acid of prM protein has converted mild forms of 
the West Nile virus into a highly virulent strain. It is more 
deadly disease detected in American crows. WNV is en-
demic in Israel and its outbreaks have been reported in re-
cent years [21]. WNV is detected in urine and serum of the 
affected patient with low-level of neutralizing antibodies. 
Most of these patients are immunocompetent in which in-
fection persists for longer time due to its active replication 
of virus. WNV generates low viremia levels during infec-
tion [22]. 
2.6 Zika Virus
Zika virus spreads through infected Aedes species 
mosquito (Ae. aegypti and Ae. albopictus). Name of the 
virus is derived as, it was first reported from Ziika Forest 
of Uganda, in 1947. Its maternal-to-fetal transmission 
also occurs during pregnancy. Virus also viremia in non-
human primates that causes urban transmission of Zika 
virus and the main reason behind its recent emergence [23]. 
Virus shows close similarity to dengue, yellow fever, and 
Japanese encephalitis and West Nile viruses. Virus take 
patients in grip of fever, develop rash, joint pain and red 
eyes and paralysis. Virus spread to lymph nodes and reach 
to the bloodstream. Virus also attack pregnant women, and 
generates birth defects in new born babies. Since 1950s, 
virus invaded equatorial belt from Africa to Asia. During 
2007 to 2016 it was spread eastward, across the Pacific 
Ocean to the Americas, leading to the 2015 -2016 Zika vi-
rus epidemic. Recently ZIKV virus has acquired mutation 
in its envelope gene (E-V473M) that is responsible for an 
increase in virulence, infectivity and mortality (Table 2).
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2.7 Rabies
Rabies is a zoonotic disease spread by infected stray 
mammals dogs and cats, wolves and other animal species 
[24]. Its person-to-person spread transmission is very rare 
(Table 2). But virus is transmitted to humans and other 
animals through close contact with saliva from infected 
animals through bites, scratches, licks on broken skin 
and mucous membranes. Rabies is caused by rabies virus 
(RABV) which challenge central nervous system function 
very severely. 
For RABV pathogenicity a G protein is responsible. 
In experiments through mutagenesis G protein mutations 
have been studies in virulent strain. However, replacement 
of Gly349 was replaced by Glu349 in G did not significantly 
influence viral growth but is enhancing the immunogenic-
ity of GD-SH-01 in periphery and induced more expres-
sion of interferon alpha (IFN-α) in the brain in mice. This 
site G349 in G proteins also leads to attenuation of patho-
genicity of RABV [24].
However, an antigenic double mutant of rabies virus 
CVS strain (challenge virus standard) is used for genera-
tion of monoclonal antibodies. However, two neutralizing 
anti-glycoprotein monoclonal antibodies, both specific for 
antigenic site III were generated for therapeutic purposes 
[25]. In these double mutants two amino acid substitutions 
have been done in the ectodomain of the glycoprotein and 
lysine in position 330 and the arginine in position 333 
were replaced by asparagine and methionine respectively. 
This double mutant virus could not penetrate the nervous 
system, more specially sensory or motor neurons, while 
single mutants infect and target motoneurons in the spinal 
cord and sensory neurons in the dorsal root ganglia of 
man. These double mutant were isolated from infected 
BHK cells, neuroblastoma cells in vitro experiments [26]. 
However, genetic and/or antigenic differences found in 
Rabies virus and vaccine strains could be used to generate 
potentially more efficacious rabies vaccines [27]. For instant 
control of Rabies keep away children from the reach of 
stray dogs, even pats and livestock and vaccinate pats and 
stray for primary prevention of Rabies [27] (Table 2).
2.8 Rift Valley Fever
Rift Valley fever (RVF) is a zoonotic spread by bites 
of infected mosquitoes to humans (Table 2). RVF virus is 
not transmitted from person to person but there are reports 
about its transmission through blood transfusion or infect-
ed organs of donors. Human is also infected with RVF by 
ingesting the unpasteurized or uncooked milk of infected 
animals. Human infections have also resulted from the 
bites of infected mosquitoes, most commonly the Aedes 
and Culex mosquitoes and the transmission of RVF virus 
by hematophagous (blood-feeding) flies is also possible. 
The virus can be transmitted to humans through the han-
dling of animal tissue during slaughtering or butchering 
and disposal of carcasses or fetuses. Persons who take 
care of livestock, conducting veterinary services infected 
easily. In addition, occupational groups such as herders, 
farmers, slaughterhouse workers, and veterinarians higher 
risk of infection. Virus directly transfers from infected 
mice to working man or through contact with broken skin, 
or through inhalation of aerosols produced during the 
slaughter of infected animals. 
RVF varies virus has a short incubation period of 2 to 6 
days. Disease starts with a mild fever, which after 4 days 
suddenly changes in flu-like fever, muscle pain, joint pain 
and headache. Some patients develop neck stiffness, sen-
sitivity to light, loss of appetite and vomiting. RVF virus 
causes ocular (eye) disease (0.5 -2% of patients), menin-
goencephalitis (less than 1% of patients) and hemorrhagic 
fever (less than 1% of patients). RVF patients also face 
hemorrhagic fever, encephalitis, and sometimes blindness.
RVF virus has acquired mutations (4 and 2) in M and 
L segments of MP-12 reported in ZH548 subpopulations. 
These subpopulations homology in nucleotides at the mu-
tation site in the Egyptian strains [28]. Other strains of this 
virus isolated are ZH501, ZH1776, and ZS6365. A recom-
binant rMP-12 is also prepared and it contains very low 
numbers of viral subpopulations.
RVF can be controlled by animal vaccination that 
should be done before an outbreak. Larvicides must be 
used to kill mosquito larvae in breeding sites. People 
should avoid raw milk and meat, and they should be well 
cooked before eating. In addition, RVF outbreak also oc-
curs due to climatic impact. In East Africa disease spreads 
only after heavy rainfall that occurs during the warm 
phase of the El Niño -Southern Oscillation (ENSO) phe-
nomenon. 
2.9 Rubella Virus
German measles is also known as rubella, this virus 
spread with air and causes a red rash on the body. About 
two to three weeks after exposure patient feel mild fever 
and headache, fever, muscle pain, headache, runny or 
stuffy nose and swollen lymph nodes. In pregnant females 
Rubella virus causes congenital rubella syndrome and dis-
rupt the development of the baby and give rise to serious 
birth defects, such as heart abnormalities, deafness, and 
brain damage. This is a highly contagious virus spreads 
through close contact or through the air. It may pass from 
person to person due to exhaled tiny drops of fluid from 
the nose and throat after sneezing and coughing. 
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Rubella virus (RV) virions contain two glycosylated 
membrane proteins, E1 and E2, which exist as a heterod-
imer and form the viral spike complexes on the virion 
surface. This E1-E2 heterodimer ensures transportation of 
E1 out of the endoplasmic reticulum lumen to the Golgi 
apparatus and plasma membrane. Hence, substitution of 
serine at Cys82 (mutant C82S) or deletion hydrophobic 
domain (mutant dt) of E1 destroy its conformational struc-
ture. Thereby it cell surface expression of both E1 and 
E2. Similarly, substitution of either aspartic acid at Gly93 
(G93D) or glycine at Pro104 (P104G) is never required 
for E1-E2 heterodimer formation and not for transport of 
E1 and E2 at the cell surface [29]. Besides this, 13 different 
mutations were found in the nonstructural protein open 
reading frame (NSP-ORF), five in the structural protein 
open reading frame (SP-ORF) and three in the untranslat-
ed regions (UTRs) (one in each three UTRs). These muta-
tions also occur in amino acid substitutions at ten residues. 
TO-336 vaccine strain (TO-336vac) of rubella virus and 
its wild progenitor virus (TO-336wt) genome sequences 
showed 21 differences in the nucleotide sequences be-
tween the TO-336vac and the TO-336wt. Mutations M33 
(wild viruses), and RA27/3 and Cendehill (vaccine virus-
es) mutations responsible for attenuation of vaccine strain 
[30] (Table 2). Rubella Children having an age between 1 to 
6 year of age should vaccinate (Table 2).
2.10 Alkhurma Hemorrhagic Fever 
Alkhurma hemorrhagic fever virus is a Flavivirus 
(AHFV) (CDC 2017). It causes hemorrhagic fever 
through tick bites. In beginning FHV infected person 
shows simple symptoms i.e. chill, mild fever, headache, 
joint and muscle pain, vomiting, and loss of appetite. But 
after 8 days patient faces neurologic, central nervous sys-
tem, and hemorrhagic problems. Patient feels heavy dis-
comfort, epitasis, hallucinations, disorientation, convul-
sions, and features of life-threatening epistaxis [31]. Virus 
infection elevated liver enzymes, leukopenia, proteinuria 
and thrombocytopenia, which leads to hemorrhagic fever 
and encephalitis (Table 2). First time this virus was initial-
ly isolated in 1995 from a patient in Saudi Arabia.
2.11 Yellow Fever
Yellow fever is transmitted by infected by Aedes ae-
gypti, throughout the tropics and subtropics. Due to illness 
causes jaundice that is why it named as yellow fever. Pa-
tient feels fever, headache, jaundice, muscle pain, nausea, 
vomiting, fatigue and acute hemorrhage. For control of 
yellow fever, mosquito vector population must be con-
trolled in the area regularly. Vaccination is used for pro-
phylaxis mainly day visitors, field workers and travelers 
those who move in infected areas (Table 2).
Yellow fever virus belongs to genus Flavivirus. This is 
an enveloped positive-, single-stranded virus of 40 -50 nm 
in width and contains 10.862 nucleotides [32]. Virus pos-
sess a single open reading frame encoding a poly-protein 
which is disintegrated into three structural (C, prM, E) and 
seven nonstructural proteins (NS1, NS2A, NS2B, NS3, 
NS4A, NS4B, NS5) by host proteases [33]. This arrange-
ment is also found same in the protein coding genes in the 
genome. [33] Yellow fever virus (YFV) 3’UTR region is 
required for stalling of the host 5’-3’ exonuclease XRN1. 
The sfRNAs also form from incomplete degradation of 
the viral genome by the exonuclease that is responsible 
for viral pathogenesis [34].
2.12 Ebola Virus Disease 
EVD (Ebola virus disease) is a rare and deadly disease 
in people and nonhuman primates. EVD mainly occurs 
in sub-Saharan Africa and it is a viral hemorrhagic fever 
of humans and other primates caused by ebolaviruses [35]. 
Fruit bats are believed to be the carrier and transmission 
vectors of this virus. Virus is also transmitted through 
breast milk, blood and semen. Infected people carry this 
virus for several weeks to months even after his/her recov-
ery (WHO 2014) [35]. Normal symptoms of disease appear 
after two days and three weeks after receiving the virus 
[36]. EV causes fever, sore throat, muscular pain, and head-
aches and severe bleeding, and organ failure mainly liver 
and kidneys. Severely affected patient begins bleeding 
both internally and externally that causes their death. This 
is sudden shock occurs due to loss of fluid from blood and 
plasma [37].
Ebola virus (EBOV) virus has acquired dominant 
mutations which are responsible for enhanced virulence 
or tropism. Ebola virus shows mutations in the glycopro-
tein [GP], nucleoprotein [NP], or RNA-dependent RNA 
polymerase [L]. Its EBOV variants carry A82V in the 
glycoprotein (GP), R111C in the nucleoprotein (NP), or 
D759G in the RNA-dependent RNA polymerase (L) [38]. 
Both NP and L mutants showed replication in monkey 
Vero E6, human A549, and insectivorous bat Tb1 cells. 
Its L mutant is less virulent whereas the GP mutation 
shows a slight increase in virulence but mainly impacts 
viral tropism. A single substitution mutation inEBV gene 
impacts its pathogenicity while amino acid replacement in 
EBOV severely affect host immune system as it obstructs 
activity of interferon-alpha, interferon-beta, and interferon 
gamma. There is a need to rational design of efficacious 
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2.13 Chikungunya Virus 
Chikungunya virus (CHIKV) belongs to genus alpha-
virus. It causes epidemic fever, rash and polyarthralgia in 
Africa and Asia. Both Aedes aegypti and Aedes albopictus 
are transmitting vectors. Two outbreaks Chikungunya 
have been reported so far, first is reported from in Malay-
sia, in Klang, Selangor (1998) and another Bagan Pan-
chor, Perak (2006). Symptoms appear two to twelve days 
after initial exposure to virus. Patient shows problems 
like headache, muscle pain, joint swelling and a rash and 
chronic arthritis. Due to similarities in clinical presenta-
tion with dengue, CHIKV is probably often under-diag-
nosed or misdiagnosed as dengue. Till date no vaccine 
or antiviral therapy is being available for prevention and 
control of this. But medical treatment with few antibiot-
ics and vector control is only tools to check the disease. 
CHIKV is epidemiologically linked to other virus gener-
ated ongoing local or international outbreaks in endemic 
areas [39].
2.14 Poliomyelitus
Poliomyelitis virus is transmitted through air and feces 
of infected patients. Virus causes paralysis of limbs. Re-
cently few cases of drug resistant and vaccines derived vi-
rus strains have been detected in clinical samples collected 
from four African countries. Here, just after polio vacci-
nation, more children were found paralyzed by attack of 
vaccine-derived virus. There were three natural or “wild” 
type polioviruses from which type 2 was eradicated in 
2015. Since more than 20 years, no mutant viruses derived 
from the type 2 polio vaccine (OPV2) have been identi-
fied. Vaccination with OPV2 is currently the only avail-
able method to induce immunity and prevent transmission 
among children. OPV2 risks seeding more of the mutated 
poliovirus mainly d (delayed) mutants. The d character is 
evolved when virus is cultured under gradual decrease of 
acid agar to recognize the susceptibility of the host cells to 
d virus. The optimal growth conditions were a narrow pH 
range that results in reduced neuropathogenicity [40]. The 
attenuated Sabin strain of poliovirus type 1 (PV-1) differs 
from the neurovirulent PV-1 Mahoney strain by 55 nucle-
otide mutations. Only one of these mutations (A-480---G), 
in the 5’ noncoding (5’ NC) region of the genome, showed 
strong attenuating effect. In the past 11 mutations in this 
region of the Sabin 1 genome, and in particular a mutation 
in the polymerase gene (U-6203--C, Tyr-73-*His), were 
found to be involved in the attenuation of PV-1. A new 
mouse-adapted PV-1/PV-2 chimeric strain v510 has been 
prepared by mutagenesis of locus 6203. This new hybrid 
v510/Sabin 1 (C-6203--U) carrying the downstream 1,840 
nucleotides of the Sabin 1 genome including the 3D”” and 
3’ NC regions [41] (Table 2). 
2.15 Mumps Virus
Mumps virus is transmitted through air; it causes men-
ingitis and inflammation of testicles in adults. Mumps 
virus, possesses one unique V protein that can assemble 
a ubiquitin ligase complex from cellular components. It 
causes destruction of cellular signal transducer and activa-
tor of transcription (STAT) proteins. V proteins target the 
interferon-activated STAT1 or STAT2 protein and STAT3 
proteins. It causes ubiquitin modification and protea-
some-mediated degradation. If single amino acid substi-
tution is being made in the mumps virus V protein, E95D, 
it results in defective STAT3 targeting, but the ability to 
target STAT1 remains intact. E95D mutation disrupts the 
ability of the V protein to associate with STAT3 [42]. For 
treatment of mumps affected pregnant women hyperim-
mune globulin are provided. It instantly works against 
virus that is displayed in reduction of symptoms (Table 2).
2.16 AIDS
AIDS, the Acquired Immune Deficiency Syndrome is a 
sexually transmitted disease caused by the human immu-
nodeficiency virus (HIV). HIV transmits from one person 
to another through bodily fluids such as blood, semen, 
vaginal fluids, and breast milk. It spreads carelessly by 
unprotected sex with an HIV infected person or directly 
from receiving of HIV-infected blood or sharing infected 
injection syringes, needles, and other clinical equipment. 
It is also transmitted through open wounds, or mucous 
membranes of eyes, mouth, rectum, and vagina. The 
risk of HIV infection from any single sexual exposure is 
generally low, but receptive anal intercourse is the high-
est risky sexual activity, followed by receptive vaginal 
intercourse. Oral sex is very low risk, and HIV cannot be 
transmitted through saliva, sweat, or tears.
Approximately more than 1.2 million American people 
are infected with HIV, and almost a fifth (18.1%) of HIV 
infected Americans are unaware of their status. There is 
a large percentage of ethnic Americans which have HIV 
but never tested for the disease that is too risky to map 
the population. According to World Health Organization 
(WHO) estimates there are more than 70 million people 
infected with HIV from which 35 million people have 
died of AIDS since the beginning of the pandemic. The 
most infected group is 0.8% of adults between 15 and 49 
years of age are living with HIV worldwide. Sub-Saharan 
Africa continues to be the most affected region, reporting 
an average of 1 in 20 adults living with HIV. In the United 
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States the number of HIV survivors because of availabil-
ity of medications that treat HIV, but in under developed 
countries people are facing severe morbidities and dying 
of the disease.
Recently three mutants of human immunodeficiency vi-
rus type 1 (HIV-1) (reverse transcriptase V106A, V179D, 
and Y181C) have been identified in clinical isolates. These 
show resistance to non-nucleoside reverse transcriptase 
inhibitors (NNRTIs). More specially, abnormalities were 
noted in RNase H cleavages which are common character-
istics of HIV-1 mutants resistant to NNRTIs. These DNA 
3′-end- and RNA 5′-end-directed cleavages are associated 
with significant reductions in the replication fitness of 
HIV-1 [43]. CCR5-delta 32 mutation is responsible for the 
two types of HIV resistance. This mutation provides abil-
ity to HIV to infiltrate immune cells. This mutation also 
slightly changes CCR5 co-receptor on the outside of cells 
to develop smaller than usual and no longer sit outside of 
the cell. It is true that not all human immunodeficiency 
virus (HIV)-1 -specific immune responses are equally ef-
fective in controlling HIV-1 replication. 
From multiple immune-driven sequence polymor-
phisms HIV-1 Gag region of transmitted viruses found 
highly conserved, it is associated with reduced viral rep-
lication in newly infected humans. These conserved viral 
regions can be used to develop an effective HIV-1 vaccine 
[44]. There is a need of large scale clinical investigations 
on infectivity of HIV, mutations and pathogenicity caused 
by HIV. Similarly, detection of immunological abnormal-
ities associated with HIV, can disclose major reasons of 
morbidities and mortalities in rural, suburban clusters and 
urban population. A world level immune surveillance be 
needed to find out HIV infected groups, and clinical status 
and deaths occurred. It will also help in display of symp-
toms, treatment, public awareness and socio-economic 
reasons of disease (Table 1 and 2).
Both chlamydia and gonorrhea are AIDS associated 
with bacterial infections and treatable by drug therapies, 
treated with medication. In women, Chlamydia in women 
causes pelvic inflammatory disease (PID), that results in 
infertility, chronic pelvic pain, or tubal pregnancies. In 
males it appears in form of urethral infection with swollen 
testicles or upper genital tract. Especially gonorrhea is 
seen in both male and female partners having HIV infec-
tion. There is a third opportunistic i.e. syphilis caused by 
bacteria in STD patients. Common symptoms of syphilis 
are ulcer or chancre, mild fever, fatigue, headache, or rash. 
Bacterial infection also causes mental illness, blindness 
and death. Syphilis is treatable with antibiotics. Syphilis is 
an incubating disease that left untreated can cause mental 
illness, blindness and death. There are many other STDs 
including: genital warts, human papillomavirus (HPV), 
and genital herpes.
2.17 Hantavirus Infection
Hantavirus infection is a viral disease that transmitted 
from rodents Apodemus agrarius mice and carried by 
Rattus norvegicus rats to people. This virus causes severe 
infections in lungs and generates cough and shortness of 
breath. It also affects kidneys cause rash and abdominal 
pain [45]. Hantavirus causes pulmonary syndrome (HPS) 
cause fatal, respiratory disease in humans. Hanta virus 
generated renal syndrome (HFRS) is a serious public 
health problem in the People’s Republic of China. Till 
date7 sero/genotypes of Hantaviruses have been isolated 
from rodents. Hantavirus seek I532K/S1094L mutations in 
DOBV Gn/Gc. However, incorporation of these mutations 
into hantaviral Gn/Gc proteins generate rVSVs a robust 
replication-competent that could be used for preparation 
of new vaccines [46] (Table 2). Hanta virus infection is vac-
cine preventable.
2.18 Enterovirus D68
Enterovirus D68 (EV-D68) was first isolated in Califor-
nia in 1962 and again in 2014 in U.S. outbreak. Since then 
this virus has spread worldwide in the current century. 
Previously, it was suspected as a polio-like disorder called 
acute flaccid myelitis. Just after beginning of infection 
patient displays common symptoms like cold, runny nose, 
sore throat, cough, and fever, variable rashes, abdominal 
pain and soft stools. After completion of 5 days it causes 
respiratory problems and generates flu-like symptom [47]. 
Patients feel difficulty in breathing as pneumonia rises. It 
increases the dehydration of body and concentrated the 
urine. Now virus affects the nervous system, specifically 
spinal cord gray matter, muscles and disturb reflexes in 
the body.
EV-D68 virus has acquired six kinds of gene mutation, 
M291T, V341A, T860N, D297N, S1108G, and R2005K 
in a distinct clade B1 of EV-D68 strains from U.S. [50]. 
These mutations have increased the neurovirulence of EV-
D68. Till the date no vaccine, and specific drug regimen 
is available to treat the EV-D68 disease. People recover 
naturally but few need hospitalization. But only symp-
tomatic patients are provided antiviral drug pleconaril [49]. 
(Table 2). EV-D68 generated paralysis cases are treated 
with steroids, intravenous immunoglobulin and/or plasma 
exchange. EV-D68 generated paralysis cases are treated 
with steroids, intravenous immunoglobulin and/or plasma 
exchange. But in some cases even after treatment no re-
covery of motor function was observed [48]. 
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2.19 Influenza 
Influenza is an acute respiratory tract infection caused 
by influenza virus. It’s three strains A, B and C have been 
detected, among which influenza A strains cause pandem-
ic. Influenza outbreak occurs repetitively is virtually every 
year, but at few places its incidence rate gets increased. 
This also reality influenza epidemics occur at intervals of 
two to three years, and pandemics at intervals of about 10 
to 15 years. Disease exists all over the world and affects 
millions of people. First pandemic was seen last century 
in 1918-19, and affected approximately 500 million peo-
ple and more than 20 million deaths. In India alone, over 
six million people died during this pandemic. The trans-
mission of influenza virus occurs from reservoir hosts like 
pigs, horses, birds but latent infection or continuous trans-
fer also occurs from one person to another. H3N2 influ-
enza A viruses are re-assorted due to mutations and show 
inter-specific and intra-species transmission [51] (Table 2). 
In year 1957-58 pandemic caused by a new strain of vi-
rus influenza A (H2N2) and again repeated 1968 but caus-
ative agent was H3N2 strain of influenza A virus. Type 
C virus also causes influenza but it is not so severe and 
occurs sporadically. Influenza A (H2N2) suddenly evokes 
and spreads very rapidly in human population. Virus has 
a very short incubation period. In a short span of time a 
large section of human society get infected, and virus over 
throw the patient immunity.
Swine influenza is caused by Swine influenza virus 
or swine-origin influenza virus (S-OIV). The important 
reservoirs Swine influenza virus are pigs and virus com-
monly house in pig populations worldwide. influenza, 
swine flu, hog flu and pig flu is an infection caused by any 
one of several types of swine influenza virus. Both Swine 
influenza virus (SIV) or swine-origin influenza virus 
(S-OIV) strain of the influenza virus are endemic in pigs. 
In year 2009 and onwards disease was spread by influenza 
C and various serotypes of influenza A virus i.e. H1N1, 
H1 N2, H2N1, H3N1, H3N2, and H2N3. Thus Swine flu 
is zoonotic rather than simple influenza. People with reg-
ular exposure to pigs are at increased risk of swine flu in-
fection. These strains of swine flu rarely pass from human 
to human. Symptoms of zoonotic swine flu in humans are 
similar to influenza and of influenza-like illness, namely 
chills, fever, sore throat, muscle pain, severe headache, 
coughing, weakness and general discomfort.
Influenza A virus (IAV), is highly infectious respiratory 
pathogen it is causing threat to global public health. In-
fluenza virus genes evolve two to three times faster than 
the corresponding genes in B viruses [52]. It is reported that 
NS gene of influenza A virus A/WSN/33(H1N1) (WSN) 
display 1.5 × 10−5 mutations per nucleotide per infectious 
cycle [53]. Virus has acquired significant modifications. 
Virus has attained significant modifications in the recep-
tor-binding specificity due to changes at gene level and its 
concerned protein [54] (Table 2). This remarkable mutation 
in surface proteins (HA (hemagglutinin) and NA (neur-
aminidase) give rise antigenic drift that is the main prob-
lem in generation of vaccine.
3. Acute Respiratory Disease
Severe acute respiratory syndrome (SARS) is a zoo-
notic disease. It is caused by SARS coronavirus (SARS-
CoV). First time it was evoked in November 2002 and 
July 2003, in southern China with 8,096 reported cases of 
infected and 774 deaths. Majority of cases were reported 
from Hong Kong with 9.6% fatality rates. From Hong 
Kong SARS spread to 37 countries in early 2003 and af-
fected millions of people. Aagin disease is remerged in 
November 2019 in China from where is spread whole of 
Europe, African countries, U.S.A, Canada, Brazil, Austra-
lia and heavily attacked South-East Asian countries and 
Russia as well. Covid-19 viral infections alone posed a 
significant global health challenge in the present time. It 
has affected millions of people worldwide, and showing 
its high aggression in Europe, America, China, Brazil and 
India after making millions of fatalities. Virus specially 
targeting young people age between 15 to 45 years of age. 
It is also affecting children and old age people both. India 
is also on war path and fighting against the second wave 
of corona virus generated by various mutant strains. As 
nature of viruses, this corona virus assumed mutation by 
its own, but it cannot be denied a rapid lethal mutation is 
only possible in laboratory. Now this is much speculated 
that this virus might have spilled out from some defense 
laboratory. Un-imaginable Covid-19 is spread worldwide 
within 120 days and has gripped whole of world in its 
fatal clutches. Virus has been imposing a serious public 
health threat and making heavy economic losses to human 
society mainly to world economy.
Covid-19 is more disastrous as it is causing high in-
fectivity and large numbers of deaths that have been 
reported round the globe [55]. Coronavirus grows in up-
per respiratory tract and is released in open air through 
sneezing and coughing by patient. Thousands of micro 
aerosols or small droplets suspend and virus live for two 
three hours in air and enter inside next host human body 
through inhalation of air [56] (Table 1). Seasonal climatic 
changes like humidity and temperature enhance the im-
pact of virus. Because ambient humidity present in atmo-
sphere raise the respiratory droplet size and its stability 
as water content evaporates. Two physical changes occur 
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in sneezed air. First droplet size gets increase with down 
pouring rain drops that quickly come to the ground. Small 
humidified aerosols remain suspended in air for longer 
time after evaporation. People on road by accident inhale 
these influenza virus loaded aerosols with respiratory air. 
Few eco-climatic factors such as relative humidity assist 
in formation of water- droplets in atmosphere, when they 
come down increasing the settling of large droplets on 
the ground and virus get inactivated. Torrent rains also 
assist in removal of infection with rain water, and largely 
influences viral transmission. First rains though help in 
washing of suspended air droplets of infectious agents but 
humidity in soil increases the stability, transportation and 
natural spread of virus from human spits, faces, drainag-
es and wastes cannot be denied. Thus sudden change in 
weather or climatic factors other than precipitation also 
affects seasonal infection rates. Areas where no air pollu-
tion is available and fouling air is least they remain devoid 
of any infection. Mainly in open climate of villages and 
single storey housing pattern and spatial separation of one 
village to the other decreases virus transmission mainly, 
but ill habits of smoking, spitting, and tobacco chewing 
and open drainages provide space and stay to this deadly 
virus and add risk to transmission (Table 1) [57]. In urban 
areas due to high density of population amount of con-
tagious air increases in air, less wind movements, close 
air circuits enhance the transmissibility of viruses. If foul 
smell released from stacked toilets in multistoried build-
ings due to pipe leakage it mixes in air currents flowing 
through indoor spaces. It spreads in nearby spaces with 
the virus particles suspended in air. With this population 
inter-mixing in crowded places will increase the passive 
transmission of this virus that may prove more fatal. 
Coronavirus is a highly mutable virus and can attain 
both negative and positive mutations according to chang-
ing physical climatic factors mainly seasonal variation in 
temperature, relative humidity, rainfall, wind velocity, day 
light, altitude and gravity. Besides, environmental factors, 
non-environmental factors such as human behavior, inter-
action, family and social structures show proximity and 
lack of social distancing increase the intensity of virus 
infection [58]. 
However, in response to climatic changes virus has 
increased its genetic susceptibility by acquiring important 
mutational changes in genes and proteins. Recently muta-
tions two mutations have been reported in severe acute re-
spiratory syndrome coronavirus 2 (SARS-CoV-2) virus in 
comparison to Wuhan-Hu1 or USA-WA1/2020 [59]. SARS-
CoV virus replicase polyprotein ORF1b has undergone 
towards negative selection that has given rise significant 
changes in spike protein gene [60]. Besides this two key 
mutations to the outer spike portion of the virus have been 
observed in B.1.617 variant. In addition, its new variants 
have been detected in the United Kingdom, Brazil and 
South Africa with much enhanced threat level. The Indi-
an variant has been isolated from Maharashtra where it 
is causing high infectivity and mortality. This variant is 
climate induced and displaying a high infection rate. This 
variant has overpowered the prior immunity of patients 
within initial days of infection and causes high mortality.
It is amazing that in a short period of less than two 
years SARS-CoV-2 virus has mutated thrice and its dif-
ferent variants have been evolved. These new environ-
mentally induced mutant variants of SARS-CoV-2 are 
very rapidly circulating in the population mainly in urban 
areas. Due to spread of these mutant variants both infec-
tivity and mortality of COVID-19 have been significantly 
increased [61]. These also have acquired resistance to exist-
ing treatment options both drugs and vaccines. Changes 
in the viral genome can result in changes to viral proteins 
and, therefore, can also impact the performance of an an-
tigen or serology test. Genetic variants of SARS-CoV-2 
due to change in antigen escaping are challenging immu-
nodiagnostic tests and samples are tested as false negative 
results. 
About SARS-CoV-2 mutations no one can emphati-
cally say that how many times virus will mutate. But it 
can be presumed that re-infection by mutated strains will 
increase the infectivity and transmission very rapidly and 
human population is going towards herd immunity [62]. It 
will become possible only when a large portion of a com-
munity becomes immune to a disease through vaccination 
or through the mass spread of the disease. Though, it will 
keep vulnerable people at risk of severe disease, since the 
virus can move through the herd to reach them. 
These double i.e. variant B.1.617 [63] and triple mutants 
variant B.1.618 are circulating in Indian states; Delhi, 
Maharashtra and some other places and are responsi-
ble for sudden origin and rapid hike of second wave of 
COVID-19. Recently, variant B.1.618 was reported from 
West Bengal that has shown much increased transmis-
sibility and ability to diffuse and weaken the immune 
response generated by host body. The double mutant in 
India carried two mutations—E484Q and L452R—in 
the crucial spike protein part of the pathogen. Both the 
E484Q mutation (reported in both UK and South African 
variants) and L452R mutation (found in the California 
strain) have been associated with much greater binding 
and antibody escape capabilities. Virus is acquiring capa-
bility to more severely challenge human immune system 
and overpowering prior immunity. More especially dele-
tion of two amino acids (H146del and Y145del), E484K 
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Table 3. showing various lineages of corona virus, mutations in spike protein genes, its impact on transmissibility, le-
thality, neurovirulence and vaccine efficacy.
Lineage Former identification Detected in country Effect of mutation on transmission
Effect on  lethality, 
virulence and vaccine 
efficacy 
Lineage B.1.1.7 / 
Variant of Concern 
20DEC-01
Lineage B.1.1.7 or 20I/501Y.
V1 (formerly 20B/501Y.V1).
First detected in  United Kingdom in 
October 2020 
40% -80% increased 
transmissibility
Increase in lethality, but 
no evidence of increase in 
virulence
Variant of Concern VOC-202102/02, Public Health England (PHE) as “B.1.1.7 with E484K
 B.1.1.7 with E484K mutations, 
increased 15-20% transmission Increase in lethality
Lineage B.1.1.207 Similar to UK’s Lineage B.1.1.7.
Reported from Nigeria in August 
2020 in Nigeria, and 16 more 
countries
Variant shows 40% -80% 
increase in transmission Increase in lethality
Lineage B.1.1.317 Not an VOC Brisbane, Australia Rapid spread in human population 
Increase in lethality, but 
no evidence of increase in 
virulence
Lineage B.1.1.318  VUI (VUI-21FEB-04, VUI-202102/04 Reported in UK
Rapid spread in human 
population
Increase in lethality, but 
no evidence of increase in 
virulence
Lineage B.1.351





Three mutations in spike 
glycoprotein of the virus: N501Y, 
K417N, and E484K. The N501Y is 
reported from U.K. United Kingdom 
and African countries
Targeting young people
Responsible for  second 
wave of the COVID-19 
epidemic in the country 
Lineage B.1.429 / 
CAL.20C
 CAL.20C in California, the 
variant
Five mutations i.e. I4205V and 
D1183Y in the ORF1ab-gene, and 
S13I, W152C, L452R in the spike 
proteins S-gene
Acquired ~20% increase in 





Lineage B.1.525 Previous VUI-202102/03
E484K-mutation in P.1, P.2, and 501.
V2 variants, deletion of the amino 
acids histidine and valine at positions 
69 and 70. UK and Denmark
Increase in transmission  Variant under investigation




Lineage B.1.617 B.1.617 or VUI-21APR-01
Mutations in spike protein D111D 
(synonymous), G142D, P681R, 
E484Q and L452R, India
Escape from antibodies ‘Variant under investigation
Lineage B.1.618 CoV-Lineages
Mutation E484K, reported in West 
Bengal, India and eight other 
countries
Acquired increase in infectivity ‘Variant under investigation
Lineage P.1 Previous VOC-202101/02 Mutation in spike protein, mutations: N501Y, E484K and K417T. England Acquired increase in infectivity  P.1 variant 
Lineage P.3 VUI-21MAR-02 Mutations in spike protein, reported in U.K. Philippines,  Malaysia 
Transmissibility is yet to be 
ascertained. P.3 variant
*P.1 and P.3 variants are evolved from the lineage B.1.1.28, 
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and D614G variants in spike protein have acquired higher 
infectivity and lethality. 
From phylogenetic analysis of genome sequence a pre-
dominant clade of SARS-CoV-2 was found, and named as 
lineage B.1.617. It displays common signature mutations 
D111D, G142D, L452R, E484Q, D614G and P681R, in 
the spike protein including within the receptor binding 
domain (RBD). More specifically, mutations are also seen 
on residue positions 452, 484 and 681 in other globally 
circulating lineages. In addition, SARS-CoV-2 is making 
substitutions per nucleotide per cell infection i.e. 10−6 to 
10−4 s/n/c [64]. This has led to increase the of copying of 
virus genome per cell and thereby enhanced per cell in-
fection. Finally, RBD mutations L452R and E484Q along 
with P681R in the furin cleavage site, has increased ACE2 
binding and rate of S1-S2 cleavage that give rise better 
transmissibility. These two mutations have decreased 
monoclonal antibodies (mAbs) binding and affecting their 
neutralization potential and challenging both therapeutics 
and immunodiagnostics [65]. For over spread and rapid 
spillover in transmission of SARS-CoV-2 fast gene re-
combination is responsible [66] (Table 3).
4. Factors Responsible for Disease Occur-
rence
In the last twenty years series of viruses generated in-
fectious diseases have been emerged and remerged [6]. The 
zoonotic microbes are continuously evolving and acquir-
ing adaptations, and showing high infectivity and mor-
tality at global level. Severity and risks of communicable 
diseases have been increased due to human movement, 
trade, recreation activities and dense population struc-
tures. Presence of pathogens in human community and its 
easy exposure is providing new hosts while eco-climatic 
conditions favoring microbial growth, transmission and 
infectivity. Further, evolution of new mutant variants of 
these pathogens have acquired high infectivity and gener-
ating catastrophic effects in human population. There are 
rising incidences of virus generated disease, flu, dengue, 
hepatitis, chikungunya, Rabies, polio, gastroenteritis and 
encephalitis throughout the globe. 
There are external factors which support disease occur-
rence, among them few important factors are heavy rains, 
water logging, high humidity, temperature difference, 
urbanization, deforestation, and human migration, settle-
ment of slums, relief camps, and nomadic movements. 
There is a lack of clean drinking water, cooking and wash-
ing. Lack of sanitation, presence of disease vectors and 
contaminated food and waste disposal are responsible for 
spread of communicable diseases. Among non commu-
nicable diseases diabetes is one of the important diseases 
that kill roughly 30 million people per year worldwide. 
Three major challenges are i.e. development of insecti-
cidal resistance in insects/vectors of potential communi-
cable diseases, drug resistance in microbes and parasites. 
Cases of lung infection, liver, kidney and gastrointestinal 
tract, child diarrhea are rapidly increasing in developing 
countries [67]. Besides, this incidence of child diarrhea [68], 
neonatal jaundice [69,70], and helminthes parasitic infections 
are spreading in developing and in third world countries. 
Due to climatic effect and drug resistance and new 
mutations in pathogens disease burden has been exacer-
bated enormously at global level. In all cases helminthes, 
protozoan’s, fungi, bacteria, virus pathogens and parasites 
available drug structure seem to be failed or their use-
fulness has been much reduced due to evolution of new 
mutant variants with multiple drug resistance. There are 
serious failures at the level of operation, management 
and control of disease. The utmost failure is due to lack 
of appropriate vaccine, drug regimens, clinical care and 
awareness among people. These are major reasons that 
are why diseases become uncontrolled and unmanageable. 
Year after year new mutant variants or climate induced 
microbial pathogen genotypes are emerging; these are not 
only challenging existing drugs but also challenging vac-
cine efficacy. This disastrous situation can be overcome 
by having new potential drug structures, control strategies 
and methods. For finding quick solutions all biomedi-
cal researches should arrange drug repurposing, testing, 
diagnosis and treatment methods with a focus on major 
human parasitic and microbial diseases. In this article 
major zoonotic infections/communicable diseases have 
been explained with their specific etiology, transmission 
and epidemiology and control/preventive measures. More 
specifically effect of climate on disease occurrence, vector 
population, drug and insecticide resistance and generation 
of new genotypes of microbial pathogens and parasites 
have been described.
5. Management Issues and Failures
Three mutants of human immunodeficiency virus type 
1 (HIV-1) reverse transcriptase (V106A, V179D, and 
Y181C), which occur in clinical isolates and confer re-
sistance to nonnucleoside reverse transcriptase inhibitors 
(NNRTIs), were analyzed for RNA- and DNA-dependent 
DNA polymerization and RNase H cleavage. All mutants 
demonstrated processivities of polymerization that were 
indistinguishable from wild-type enzyme under conditions 
in which deoxynucleoside triphosphates were not limiting. 
The V106A reverse transcriptase demonstrated a three- to 
fourfold slowing of both DNA 3′-end-directed and RNA 
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5′-end-directed RNase H cleavage relative to both wild-
type and V179D enzymes, similar to what was observed 
for P236L in a previously published study (P. Gerondelis 
et al., J. Virol. 73:5803 -5813, 1999). In contrast, the 
Y181C reverse transcriptase demonstrated a selective ac-
celeration of the secondary RNase H cleavage step during 
both modes of RNase H cleavage. The relative replication 
fitness of these mutants in H9 cells was assessed in par-
allel infections as well as in growth competition experi-
ments. Of the NNRTI-resistant mutants, V179D was more 
fit than Y181C, and both of these mutants were more fit 
than V106A, which demonstrated the greatest reduction 
in RNase H cleavage. These findings, in combination with 
results from previous work, suggest that abnormalities in 
RNase H cleavage are a common characteristic of HIV-1 
mutants resistant to NNRTIs and that combined reduc-
tions in the rates of DNA 3′-end- and RNA 5′-end-directed 
cleavages are associated with significant reductions in the 
replication fitness of HIV-1.
5.1 Malnutrition
Other than climatic factors the major factor is malnu-
trition. It is a condition generated due to intake of either 
nutrient deficient diet or some components in excess, or 
in wrong proportion. According to World Bank published 
report, India has a large number of children suffering 
from malnutrition and ranked first among the list of other 
countries. In India Uttar Pradeh has the highest number 
of malnourished or under nutrition children and comes at 
fourth number from the bottom on child nutrition rates. 
This is falling behind Bihar, Andhra Pradesh and Daman 
and Diu. In many states of Indian children in rural areas 
are facing protein and iron deficiency in food. This Pro-
tein-energy malnutrition and iron deficiency is seemed in 
form of nutritional anemia, due to which children remain 
less productive and weak. Similarly, vitamin A deficient 
food results in either blindness or a weakened immune 
system. In addition, iodine deficiency, causes serious men-
tal or physical complications. Therefore, to finish problem 
readymade therapeutic food should supplied for treatment 
of severe acute malnutrition in children from six months 
to five years of age [71]. Due to folic acid scarcity in diet 
lead to insufficient birth weight or congenital anomalies 
such as spina bifida. Hence, specially formulated foods 
should give to feed children with moderate acute mal-
nutrition in low- and middle-income countries [72]. This 
eastern part of India has bowl shaped landscape, due to 
which huge water collection takes place in pools & high 
humidity in rainy season. This region has high population 
density, malnutrition, poor sanitary conditions, contami-
nated water, poverty, illiteracy and almost every alternate 
year several serious diseases are occurring. Entire area is 
very poor in maintaining sanitation, irregular supply of 
safe drinking water and problem of wages, education and 
employability. 
5.2 Lack of Sanitation Facilities and Equipment
At global level management of child and women health, 
is not good and conditions of third world countries is 
worst. Even in few developing countries sanitation condi-
tions are not so good. Meanwhile, their urban sites are full 
of scattered slums with lots of garbage, filths, solid waste, 
and open water pools of dirty water, which are epicenters 
of mosquito breeding and other insect vectors. There is no 
authority to look after sanitation conditions, drainages and 
vector control only for slums. If these are available, most 
of them are either non-functional, low budgetary bodies 
or do not have required number of trained workers. Poor 
sanitation conditions are also responsible for spread of 
communicable diseases in rural and urban areas. In many 
poor countries large numbers of households in rural areas 
do not have toilet facility, or non speticc tank attached 
latrines, hence, people are forced to defecate in open that 
is contaminating fresh water, underground water and river 
water sources of that area and chances of communicable 
disease remain fair. In these areas flavivirus generated 
zoonotic diseases are very common of easy transmission 
due to fouling smell and presence of vectors [73]. These 
also attract insect vectors to breed. Open air defecation 
leads to the spread of disease both parasitic, bacterial and 
viral infections [73].
5.3 Problem of Safe Drinking Water
There is an utmost need to improve water supplies for 
controlling Aedes vectors, especially Ae. aegypti. Clean 
water supply and use of filters in houses and water treat-
ment can ensure reduction in water borne communicable 
diseases. Central water supply unit should provide clean, 
well treated and filtered drinking water to all households. 
For this purpose, water is drawn by pumps, from under-
ground borings or wells, and filled in central over hand 
tank by standpipes; from it is supplied to the community. 
Due to lowering in underground water table due to high 
extraction of water, for water supply rooftop catchments 
and other water-storage systems are also used. To com-
plete un-interrupted water supply, rain water harvesting 
can be done for collection of water in tanks, and recharg-
ing of wells. For, provide water supply at low subsidized 
cost in urban areas per unit/gallon charges are to be levied 
for cost-recovery and maintenance of other expenditures. 
Therefore, for fair supply of water to all, gauze-meter 
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reading boxes are to used to ensure water supply to every 
consumer of the area. To manage low cost water supply 
household collection and storage of roof catchment rain-
water must be encouraged by making underground water 
harvesting chambers. Households should clean or drain 
water-storage containers to stop larval culture in tires, 
drums, overhead plastic or concrete tanks. 
Due to supply of contaminated drinking water large 
number young age infants, juveniles, sub-adults become 
victims of diarrhea, cholera, dysentery, and hepatitis. In 
rural areas diseases like hepatitis A, enteric fever, intesti-
nal worm infections, and fungal infections of skin and eye 
flu occur due to fouling, lack of sanitation, poor hygiene 
and unsafe drinking water. People also use water from 
wells, rivers, or ponds where decontamination of water 
never done. People are using unsafe contaminated drink-
ing water in rural areas, and common water sources are lo-
cal mark taps which drain contaminated water collected in 
upper underground water table. Due to extraction of large 
portion of groundwater for irrigation local pumps, wells, 
and taps become non-functional. Insufficient maintenance 
of the environment around water sources, groundwater 
pollution, excessive arsenic and fluoride in drinking water 
pose a major threat to India’s health.
5.4 Vector Control
Without controlling disease transmission vectors, con-
trol of communicable diseases is impossible. For instant 
control of malaria, dengue fever, Japanese encephalitis 
and other pathogenic diseases mosquito control must be 
ensured by using variety of strategies i.e. using repellents, 
insecticides, fumigation are used to control adult mosqui-
toes. Deterrent or repellent treated mosquito nets, door 
nets, window mosquito mesh covers, killing of larvae 
in home outlets can cut down transmission of mosquito 
borne diseases. Infected birds, bats, dogs and other canine 
either treated with vaccine or finish by any method to con-
trol SARS, bird flu and Rabies. It is also possible through 
environmental management. By changing and cleaning 
the local environment minimize vector population can 
be minimized, with reduction human contact and bites. 
For vector control houses are regularly sprayed with low 
toxic pesticides and fumigants can be used in morning as 
well as in evening time. Larval habitats must be treated 
by using bio-insecticides, oils and soap water for dengue 
vector control. For improvement of cultural environment 
kill mosquito larvae in vector breeding habitats, keep 
vessels, bottles, buckets, coolers empty, clean them by 
scrubbing, fumigation of houses, spray of garden plants, 
waste disposal, and cleaning of gutters and drainages are 
highly essential. For complete check on mosquito breed-
ing community water supply should be provided through 
distribution pipes by connecting them with household 
connections. 
To ensure regular improvement in cultural environ-
ment street drains must be treated by low toxic insecti-
cides to kill developing mosquito Aedes. aegypti larvae 
in stagnant water. Both household, medical and garden 
pests must be controlled. There is a need to keep low 
level of chlorine treatment in treating drinking-water to 
avoid dosages, it is highly to humans. Label instructions 
when using insecticides. There must be cultural and so-
cial feeling to maintain local environment clean healthy. 
However to combat spread and infectivity of flaviviruses 
vector control, epidemiology and immune surveillance 
and other safety measures must be ensured [74]. By vector 
control both disease transmission and pathogenesis can 
be controlled instantly [75].
5.5 Solid Waste Management
Mosquitoes breeding sites are mostly in solid waste 
sites where dirty water is filled in plastics. Solid waste is 
non-biodegradable garbage that attracts pigs, mosquitoes, 
flies, cockroaches and other organisms. By applying many 
of the basic principles population of Aedes aegypti larval 
habitats can be controlled. For environmental cleaning re-
duce, reuse, recycle of waste is highly important. For safe 
disposal of community waste proper storage, collection 
and disposal of waste are must. Integrated Aedes aegypti 
control with waste management can provide greater suc-
cess in disease control. 
5.6 Urban Hygiene and Health
For urban hygiene and health, before construction of 
buildings and other housing infrastructures should circu-
lation of fresh air, housing water discharges from outlets 
should be kept in mind. Roof top rain water should be col-
lected in overhead tanks and treated with to reduce disease 
vectors, including Ae. aegypti, Culex quinquefasciatus 
and An. stephensi. For this purpose, policy framework for 
creation of housing structures allows under legislation and 
rules of housing boards and municipalities. Face of build-
ing must be East to West so that fresh air can circulate 
easily through corridors and balconies. 
5.7 Drainage and Irrigation Systems
In Tarai areas major water supply is through canals; 
that alternatively provides surface to mosquito vectors to 
breed. To stop breeding of mosquitoes subsurface drain-
age systems will prove more beneficial in control. There 
should be regulated irrigation of crop lands to control the 
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vector breeding. In alkaline soil conditions heavy water-
ing of crop lands through soil, keep salts accumulating 
in the root zone and making the soil unproductive. After 
spring season all these areas become filthy and full of 
vector population therefore, water drainage and irrigation 
systems must be well planned to drain out water or restore 
irrigation by using drip method or through pipeline to 
avoid staying and breeding of mosquitoes. Municipalities 
should set up a drainage pipe system that carries the water 
off the roof and safely away from home [76]. Water collect-
ed from rainwater harvesting can be used for irrigating 
lawn and garden plants, cleaning of clothes and utensils. 
5.8 Lack of Knowledge and Social Awareness
For better management of epidemics or pandemic 
people should be abided by the importance of social dis-
tancing and other preventive measures. This is the duty of 
government and concerned public bodies to make people 
aware about the severity and devastation caused by pan-
demics. Only following rules, norms, and value of restric-
tions and support of protective measures with a positive 
attitude can reduce the intensity of pandemics. People 
must make aware about the presence of virus, its transmis-
sion and common symptoms and prevention. They essen-
tially follow, lockdown, and maintain social distancing. 
For increasing awareness, social interactions, discussions 
and community level display are required. There is a need 
to design awareness programs to ensure participation of 
local people and thereby implement community-based 
disease or disaster management in their area. Social enter-
prises must aware about real time situations and remain 
in search, how to have saved themselves during disasters, 
pandemics and forest fires. United Nations ESCAP has 
issued directives for social enterprises to provide employ-
ment marginalized and vulnerable human communities 
and fulfill Sustainable Development Goals [77].
6. Issues Related to Health Management
6.1 Insurance-cooperative Community Health 
Services
For fighting communicable diseases coopera-
tive-health insurance policy is required to provide med-
ical treatment cover and remit clinical care expenditure. 
It must be essentially owned by the people. It should be 
formed of mutual insurance that may ensure all hospital 
entry and make clinical easy and mandatory to all the pa-
tients. It should be both publicly funded and single-pay-
er healthcare insurance organization. President Obama 
suggested that all future health insurance cooperatives 
would run by their own, and receive a partial investment 
the government and would then handed over to non-prof-
it organization [77]. Farm Security Administration (FSA) 
was running many rural health cooperatives. Un-irrupted 
health care is possible through on premium insurance 
plans with high benefits. 
6.2 Female and Child Health Issues
In developing countries child mortality is high. The 
main reason behind it is mal-nutrition. Problems are child 
marriage, delayed marriage, obesity and other physiologi-
cal ailments. Most of the mother-child health care centers 
in rural areas do not have skilled birth attendants and lack 
of quality emergency maternal care. One of the most se-
vere and increasing problems among women in India, re-
sulting in higher mortality rates due to malnutrition, breast 
cancer, and stroke, delivery and post pregnancy deaths. 
Vitamin, protein, iron and folate deficiency are responsi-
ble for child mortality. The main cause of female malnu-
trition in India is the traditional foods and social practices. 
Due to obesity and overage in females polycystic ovarian 
diseases are increasing the infertility rate in females. This 
condition causes many small cysts to form in the ovaries, 
which can negatively affect a woman’s ability to conceive 
Child marriage is a curse and making the life of young 
couples hell, because most of them are unemployed, and 
facing physical and physiological illness. In India mater-
nal mortality rates in rural areas are one of the highest in 
the world [78].
6.3 Rural Health
In developing and under developed countries 50-60% 
of total population is living in rural areas and half of all 
residents of rural areas live below the poverty line, strug-
gling for better and easy access to health care and ser-
vices. Rural areas of many countries also have local health 
issues evolved due to communicable diseases i.e. influ-
enza, dengue, filarial, rubella, Ebola and malaria. Rural 
people are also facing illness caused by life style diseases 
such as diabetes, blood pressure, obesity, cardiovascular 
problems, cancer with heavy trauma of communicable 
diseases. Malnutrition, loss of habitat, cultural and social 
detachment are serious problems in resource-poor rural 
areas. Thus, demographic, local climatic changes and 
invasion by disease pathogens are causing high maternal 
mortality particularly in rural India. Both malnourished 
mother and child need instant care and medical aids. 
6.4 Vaccination Drives
Vaccine is only way to artificially raise body’s natural 
defenses so that immune system can recognize and fight 
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off the viruses and other pathogens. A vaccine essentially 
contains an antigen or a gene that synthesize antigen that 
can generate a significant level of immune response after 
administration. But it is tje greatest challenge in present 
time as new variants/mutants of viruses are evolving, and 
these are responsible for enhancement of neurovirulence, 
anti-genicity, host immune responses and disease trans-
mission in endemic areas [79]. It has led to decrease the 
vaccine efficacy. Till the date thousand of vaccines have 
been generated against various diseases under W.H.O. 
banner under licensing. Vaccination needs pre and post 
vaccination surveillance to adjudge the successfulness of 
vaccination drive. Vaccination drives against virus and 
bacterial infections were found successful as the efficacy 
was noted between 90-97% in a few cases. After vaccina-
tion, if the body is later exposed to those disease-causing 
germs, the body is immediately ready to destroy them, 
preventing illness. Such vaccine is considered to be effica-
cious and shows success rate around 90%. It is great truth 
that vaccines save millions of lives each year [80].
In the present time vaccines are only hoped in the bat-
tle against COVID-19. There is a huge demand to vacci-
nate every person; hence there is an utmost need to speed 
up the production of safe and effective vaccines against 
COVID-19. For large scale immunization in India as well 
as in other countries manufacturing capabilities are to be 
enhanced, license and duty policy should be elasticized. 
Further, at the global level governments and manufactur-
ers must ensure to have fair and equitable allocation of the 
vaccines for all countries. But for fast control of disease 
there must be some change in vaccine policy. It must be 
de-licensed so that its manufacturing could be increased 
and cost comes lower down. If we want to defeat recent-
ly merged pandemic no patents are to be given and open 
licensing will increase manufacturing level, it will speed 
up vaccination process. Now greater questions are there 
are three categories of people in current time unvaccinat-
ed healthy, first dose takers and people recovered from 
Covid-19 infection. If people who have administered 
first dose, if they will not be provided booster dose then 
vaccination has no meaning. Now, for greater success all 
age groups should be vaccinated within six months before 
third wave, and it is seeing impossible. There should be 
a broader plate form, and a group of scientists collabora-
tors and manufactures to generate vaccines 4-5 million 
doses per week to collectively save lives and to end this 
pandemic. For control of invasion of retroviruses anti-ret-
roviral therapy could be provided. Similarly, few viral dis-
eases could be treated by using anti-viral drugs, if they are 
used after consultation with a physician in initial phase of 
disease [81].
Since the pandemic began, in India mark of infected 
has been reached beyond 30 million cases. It has also 
reported more than 200,000 deaths. About 150 million 
shots have been given, equivalent to 11.5% of India’s 1.3 
billion people. India started its Covid-19 vaccination pro-
gram in mid-January. Initially chances of success looked 
high. Though, government has formed the vaccination 
policy and categorizes the various age groups to vacci-
nate. But by seeing population size it will need more than 
two billion doses for one primary vaccination and for a 
second dose as a booster. India has fully vaccinated less 
than 2% of its 1.3 billion huge population. Therefore, rate 
of vaccine production and its administration should be 
increased. Production of vaccine at current rate is not suf-
ficient for immunization of whole country. Though, India 
is self reliant in vaccine production but it will need huge 
infrastructure to give tough fight to corona pandemic. In-
dian government has set the new rules to make “pricing, 
procurement, eligibility and administration of vaccines 
open and flexible.” The nation is now the main hotspot of 
the pandemic, despite being home to the world’s largest 
vaccine manufacturer. The vaccination program is highly 
essential to vaccinate the people to reduce the selective 
pressure for emergence of new strains. A much faster 
vaccine drive could end this pandemic much faster. Not 
just that, India is also helping out many countries with 
vaccines. Due to shortage of vaccine inoculation centers 
across the country are running short of doses. Before, 
finishing of second wave all age groups in India must be 
vaccinated. Despite being the world’s biggest producer of 
vaccines, the country is suffering an internal shortage and 
has placed a temporary hold on all exports of AstraZeneca 
to meet domestic demand.
India has been using two vaccines - the Oxford-As-
traZeneca jab (known locally as Covishield) and another 
(Covaxin) is made by Indian firm Bharat Biotech and Se-
rum Institute of India Ltd. Recently, Russian-made Sput-
nik V vaccine has been confirmed its production in India 
by end of July this year.. All these vaccines are well tested 
and passed through a double blind, randomized clinical 
trial of immunogenicity and safety on a dose-response 
study [82]. Vaccination in India is going on with few “18904 
adverse events” including 180 deaths following immuni-
zation. These adverse events were “minor” and happened 
due to anxiety, vertigo, giddiness, dizziness, fever, and 
pain. All such patients had recovered, the government 
said. More deaths were observed due to underlying con-
ditions or persons facing any life style disease including 
heart problems, high blood pressure and diabetes.
There are several reasons of vaccine failure, it occurs at 
the level of antigen purification, instability or poor stabili-
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ty of antigen, production and manufacturing time, storage, 
transport and immunization [83]. The biggest challenge to 
current vaccination is to protect the immune-compro-
mised patients and the elderly, with severe lower respira-
tory tract infections. Vaccination is only way to manage 
respiratory failure and ARDS; septic shock; prevention 
of other physiological. Vaccination is safe and provides 
protection shield against Covid-19. Besides success few 
China made vaccines were found un-reliable and totally 
failed the main reason behind is de-naturation or instabili-
ty of antigen. There are two important questions how long 
current vaccines will work against array of mutants that 
may come in future. Because low antigenic homology in 
surface proteins both vaccine and circulating strain will 
differ always. It will affect the efficacy of vaccine and 
remain insufficient to viral antigen load in the vaccine. 
Among important reasons of vaccine failures are muta-
tions in epitopic regions of viruses, poor antigenecity and 
low neutralization power. In the past several attenuated 
vaccines have been failed due to low reactogenicity and 
immunogenicity to newly formed viral strains mainly 
new mutant variants [84]. Total failure of vaccine is loss of 
efficacy of immune protection and generation of level of 
antibodies after immunization.
The main problem in control and prevention of com-
municable disease is poor economic condition of people. 
They are not in a condition to pay heavy expenditure 
occur in treatment, hence they never reach to hospitals. 
These solely depends on government hospitals and on 
international disease eradication programmes launched 
by W.H.O. Due unemployment and low availability of 
resource people are struggling for better and easy access 
to treatment and health care. Rural population in so many 
countries has severe health issues that will need social 
networking for proper clinical care. To finish disease it is 
essentially required to bring together people with educa-
tion-technology and knowledge dissemination on a single 
platform. There is no institution which can hear problems 
of slum residents, poor farmers and residents of Tarai re-
gion of eastern part of India. 
7. Conclusions
There are several causes of outbreak of communicable 
diseases. Among all reasons arthropod life cycles are more 
frequent which consequently responsible for dispersal of 
various categories of viruses i.e. arboviruses and flavivi-
ruses. These areas also have to transmit vectors and reser-
voir hosts both in the area, at the same time and in same 
season. Mosquito vectors are transmitting pathogens be-
tween various vertebrate hosts. Due to heavy rains in low 
land areas flood water collected speedily full of garbage, 
human and animal wastes, fertilizers and other chemicals. 
This large area of flood water, support large vegetation 
cover, huge plankton and fish population attracts migra-
tory birds. In addition, increase in water surface area in 
hundreds of wetlands and adjoining paddy fields provide 
a broad base to mosquitoes breeding. It occurs very fast 
because with supported supplementation of different fer-
tilizers. In addition, new migrants received by the water 
reservoirs provide blood feeding to mosquito population, 
thus transfer of pathogen between hosts becomes easy. It 
is responsible for virus multiplication and transmission. 
Once there are rains, a rapid increase occurs in vector 
population, amplifying hosts and migratory birds are seen. 
These ecological and landscape factors are responsible for 
emergence/re-emergence of virus diseases with other as-
sociating complex factors, such as viral recombination and 
mutation, leading to more virulent and adaptive strains. 
Furthermore, urbanization and human activities are cre-
ating more permissive environment for vector-host inter-
action, and increased air travel and commerce. To fight 
against the rising JE, malaria, dengue, and SARS-COV-2 
geographic, demographic, vector and host biology and cli-
matic studies are highly important. For an effective con-
trol of communicable diseases, vector control, improve-
ment of local environment, social awareness, clinical care 
and vaccination are important steps. Disease management 
is only possible after management; it will not only control 
diseases but stop its outbreak but check conversion of en-
demic diseases into pandemic. Contrary to this, Covid-19 
is spreading beyond the limits of demographic and geo-
graphical locations. Virus is equally showing mortality 
rate in temperate and tropical and subtropical regions. 
Among important reasons of outbreak of communica-
ble disease are high annual precipitation cycles, frequent 
human travels, demographic clustering, and insecticide 
resistance. Due to filth and garbage ditches mosquito’s 
larvae get adapted to chemical pesticides, from which 
insecticide resistant adult population emerged. It leads to 
transmission of disease pathogens in human population. 
Further, poor economy, socio cultural environment and 
lack of clinical care and therapeutics increase the number 
of affected people. On other side microbial pathogens 
are also developing resistance to drug structures and new 
mutant variants or revertants of many viruses are increas-
ing infectivity and mortality in the epidemiological area. 
Other complex factors related to human activities like 
deforestation, dam construction, open irrigation, and cli-
matic changes brought on by EI Nino-related events such 
as droughts, forest fires and severe haze, environmental 
gases changing the effecting the precipitation cycle. Due 
to monoculture economic crops, composite fish farming, 
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hatcheries, and mixed agro-pig farming practices are pro-
viding base to viruses, because both vectors and reservoir 
hosts remain in exposure to this fowling environment, 
hence, communicable disease pathogens easily generate 
their progenies and spillovers of the virus take place from 
wildlife reservoir hosts into pig population. Pig farming 
between the human habitations should be ceased imme-
diately and these should be shifted far away from human 
habitations. Furthermore, ecology, global warming and 
rising vector population have significantly increased the 
potential for disease emergence and its spread. For overall 
health management both surveillance and diagnosis are 
equally needed. For combating Covid -19 pandemic all 
the reasons of virus generated epidemics, virus genetics, 
host immune status, fast and earlier diagnosis, clinical 
care, long term safer immunization, vector control and 
socio-clinical management of communicable diseases be 
required in affected areas.
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